Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Oncolytic Viruses / Non-viral Gene Therapy Delivery
November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Johanna Kaufmann
Executive Vice President for Oncology at Codagenix Inc., USA
Speaker

Profile

Dr. Kaufmann is a scientific and strategic leader in immuno-oncology with broad expertise across preclinical and translational drug development. Before joining Codagenix, she was a Scientific Director at GSK, leading an immune biology group and supporting progression of multiple portfolio assets as part of the immuno-oncology senior leadership team. She previously led mechanisms of action studies for immuno-oncology assets at TESARO and headed three preclinical herpes virus vaccine programs at Genocea Biosciences. Dr. Kaufmann earned a MS in Molecular Medicine from Friedrich-Alexander University in Erlangen, Germany, and a PhD in Cancer Virology from the German Cancer Research Center (DKFZ) and Heidelberg University, Germany.

Agenda Sessions

  • The Codon-Modified Virotherapeutic CodaLytic™ Modulates the Tumor Microenvironment in Models with Different Immune Contextures

    , 9:05am
    View Session

At this event

Prev
Next
Mohammad Ali Amini
President & CEO
QurCan Therapeutics Inc., Canada

See Johanna at Oncolytic Viruses / Non-viral Gene Therapy Delivery